We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014...
Six-month interim report (Q2) 2024 Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a...
ALK upgrades its full-year revenue and earnings outlook ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the full-year financial outlook has been upgraded to reflect the current performance...
Invitation to the presentation of ALK’s results for the first six months (Q2) 2024 on Friday 23 August 2024 ALK (ALKB:DC / OMX: ALK B / AKBLF) will publish its results for the first six months...
ALK upgrades its full-year revenue and earnings outlook ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the full-year financial outlook has been upgraded to reflect better than...
ALK provides update on regulatory process for the house dust mite allergy tablet in China ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that it has decided to withdraw the Biologic...
ALK launches new growth strategy and 2028 financial ambitions ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the Board of Directors has adopted a new corporate strategy (Allergy...
ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies At the Annual Congress of the European Academy of Allergy and Clinical Immunology...
ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the European regulatory filing for...
Listen in on ALK’s Capital Markets Day on 4 June 2024 ALK (ALKB:DC / OMX: ALK B / AKBLF) will host a Capital Markets Day on 4 June at 13.00-17.00. We cordially invite investors, analysts...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.4 | -5.75657894737 | 24.32 | 24.32 | 22.92 | 739 | 23.2207255 | DE |
4 | -0.88 | -3.6974789916 | 23.8 | 24.56 | 22.56 | 463 | 23.70787901 | DE |
12 | 2.26 | 10.9390125847 | 20.66 | 24.56 | 19.13 | 445 | 22.72819901 | DE |
26 | 2.24 | 10.83172147 | 20.68 | 24.56 | 19.05 | 429 | 21.83831716 | DE |
52 | 2.24 | 10.83172147 | 20.68 | 24.56 | 19.05 | 429 | 21.83831716 | DE |
156 | 2.24 | 10.83172147 | 20.68 | 24.56 | 19.05 | 429 | 21.83831716 | DE |
260 | 2.24 | 10.83172147 | 20.68 | 24.56 | 19.05 | 429 | 21.83831716 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions